Breaks ground to expand scalable, cost-efficient facility in Junction City, Kansas Junction City, Kansas – September 6, 2017 – Ventria Bioscience Inc. today announced an expansion of biomanufacturing and laboratory facilities to roughly double Ventria’s capacity for production of recombinant proteins. The company broke ground today on the expansion of its molecular biology lab, greenhouses, process […]
News - Press
See the latest innovations and news from Ventria Bioscience as their team works to bring life-saving therapeutic medicines to the world using ExpressTec.
Ventria Bioscience announces peer-reviewed publication on novel mechanism of action in inflammatory bowel disease
Collaboration with Children’s Hospital Colorado finds Ventria’s recombinant human lactoferrin modulates immune response FORT COLLINS, Colorado – May 17, 2017 – A multi-year collaboration between Ventria Bioscience Inc. and Children’s Hospital Colorado has found a novel mechanism of action that enables Ventria’s recombinant human lactoferrin, VEN120, to reduce inflammation in models of inflammatory bowel disease (IBD). […]
Ventria Wins Economic Development Award
Ventria Bioscience was recognized on February 1 by the Junction City Area Chamber of Commerce with The Eldon L. Hoyle Economic Development Award in acknowledgement of the company’s service, commitment, support and dedication to Junction City and Geary County. Mickey Dean, interim CEO and president of the Chamber, presented the award at the Chamber’s annual […]